Introduction

Candida glabrata (recently reclassified as Nakaseomyces glabratus) is a versatile fungal microbe that exists as a natural human commensal. While it typically coexists peacefully within various body sites, it is recognized as an opportunistic pathogen. This means that under specific conditions—such as a weakened immune system or a disrupted microbial balance—it can shift from a harmless resident to a cause of infection. Known for its intrinsic drug resistance and metabolic flexibility, C. glabrata plays a complex role in the human mycobiome, impacting health across multiple biological niches.

Location of Microbe

Vaginal Ecosystem

In the vaginal tract, C. glabrata exists as part of the mycobiome. It can remain commensal or become associated with vulvovaginal candidiasis, often appearing in specific community state types (CSTs) that differ from those dominated by C. albicans.

Urinary Ecosystem

C. glabrata can colonize the urinary tract, where it is frequently associated with the formation of biofilms on abiotic surfaces, such as urinary catheters, which can facilitate deeper tissue invasion.

Gut Ecosystem

The gastrointestinal (GI) tract is a primary reservoir for C. glabrata. It colonizes the intestinal lumen and can potentially disseminate to internal organs if the gut barrier integrity is compromised.

Oral Ecosystem

In the oral cavity and pharynx, C. glabrata is one of the prevalent fungal species, often found alongside other Candida species in the respiratory and oral mucosa.

Behavior During Dysbiosis

Vaginal Ecosystem

Dysbiosis in the vagina, marked by a decrease in Lactobacillus and an increase in Prevotella, is associated with the transition of C. glabrata from a commensal state to a pathogenic one.

Urinary Ecosystem

When the local microbial balance is disrupted, C. glabrata may exhibit increased adhesion to epithelial cells and medical devices, leading to the development of resistant biofilms.

Gut Ecosystem

In the gut, C. glabrata may overgrow following antibiotic treatment that depletes bacterial diversity. It can exploit inflammatory environments, such as colitis, to increase its abundance.

Oral Ecosystem

Oral dysbiosis or systemic immunosuppression can lead to C. glabrata proliferation, contributing to fungal colonization of the pharynx and sputum.

Disease Associations

Vaginal Ecosystem

Vulvovaginal Candidiasis (VVC): C. glabrata is associated with a specific community state type (CST I) of VVC. This form of infection is often linked to the presence of Prevotella in the vaginal bacteriome and is frequently more resistant to standard azole antifungal treatments than C. albicans-led infections. Additionally, some research suggests a potential association between vaginal dysbiosis and the persistence of high-risk HPV infections.

Urinary Ecosystem

Catheter-Associated Infections: C. glabrata is associated with nosocomial infections in the urinary tract. Its ability to form biofilms on abiotic materials, such as urinary catheters, allows it to act as a physical barrier against antifungal drugs, increasing patient morbidity.

Gut Ecosystem

Clostridioides difficile Infection (CDI): Pre-colonization of the gut with C. glabrata is associated with an exacerbation of CDI, leading to more rapid mortality and increased C. difficile toxin production. Gastric Carcinogenesis: Imbalances in the gastric mycobiome, including changes in C. glabrata abundance, are associated with the progression of gastric cancer. Systemic Candidiasis: In immunocompromised patients, C. glabrata can breach the gut barrier, leading to life-threatening systemic infections and high mortality rates.

Oral and Respiratory Ecosystems

Lower Respiratory Tract Infections (LRTI): C. glabrata abundance in the lung microbiome is positively correlated with advancing age in patients with LRTI. It is also detected in the sputum of patients with acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD), contributing to varying degrees of lung inflammation.

Foods Supporting Healthy Balance

Maintaining a balanced mycobiome requires a dietary approach that supports a diverse bacterial community, which in turn keeps opportunistic fungi like C. glabrata in check. Focus on the following:

• Probiotic-Rich Fermented Foods: Incorporating foods containing Saccharomyces cerevisiae and other probiotic yeasts can be beneficial. Certain food-derived yeasts have been shown to inhibit the virulence traits of C. glabrata, such as its ability to adhere to surfaces and form biofilms.
• High-Fiber Prebiotics: Diets rich in complex fibers support the growth of beneficial Lactobacillus species, particularly in the gut and vaginal ecosystems. These bacteria produce lactic acid and other metabolites that help maintain a pH environment unfavorable for fungal overgrowth.
• Reduction of Refined Sugars: High-sugar diets can provide an excess of easily fermentable carbon sources that may fuel the overgrowth of Candida species. Reducing processed sugars helps maintain microbial diversity and prevents dysbiosis.
• Natural Probiotics: Consuming natural sources of Lactobacillus helps reestablish a healthy flora, reducing the risk of fungal-induced inflammation.

Actionable Insights

• Support the Gut Barrier: Prioritize a diverse intake of plant-based fibers to maintain gut barrier integrity, which prevents the translocation of commensal fungi into the bloodstream.
• Mindful Antifungal Use: Avoid the inappropriate or overuse of antifungal agents, as this can select for non-albicans Candida species like C. glabrata, which are more resistant to common therapies.
• Vaginal Health: Maintain vaginal microbial balance by avoiding harsh soaps or unnecessary douching, which can deplete Lactobacillus and trigger dysbiosis.
• Urinary Hygiene: For those using medical devices, prioritize strict hygiene and timely replacement of catheters to reduce the risk of C. glabrata biofilm formation.
• Age-Specific Monitoring: Since fungal abundance in the respiratory tract increases with age, elderly individuals should be mindful of respiratory health and early signs of infection.
• Probiotic Integration: Consider the use of specific probiotic strains, such as Saccharomyces boulardii, to help prevent the overgrowth of opportunistic yeasts in the gastrointestinal tract.

Conclusion

The impact of Candida glabrata on human health is highly dependent on the specific strain and the ecological niche it occupies. In a healthy state, it exists as a quiet commensal across the gut, oral, vaginal, and urinary ecosystems. However, when the host's immune system is suppressed or the microbial community undergoes dysbiosis, C. glabrata can utilize its metabolic versatility and drug-resistant nature to cause significant infection. From exacerbating C. difficile in the gut to contributing to vulvovaginal candidiasis and respiratory inflammation, its role varies by ecosystem. Achieving a healthy balance requires a combination of dietary support, judicious use of medication, and the maintenance of overall microbial diversity to prevent this opportunistic fungus from dominating its environment.